Skip to main content

Interview with the Innovators

Interview with the Innovators

 

Market Access
Interview with the Innovators
A Passion for Scientific Innovation and a Company Culture That Values Customers Drive the Teams at Genmab to Discover Cutting-Edge Solutions for People with Cancer
Brad Bailey, Chris Cozic
Read More
Market Access
Interview with the Innovators
Genmab Unleashes the Power of Strategic Alliances to Advance the Science of Therapeutic Antibodies for People with Cancer
Robyn Bilmes, Leslie Amendola
Read More
Market Access
Interview with the Innovators
Genmab Is Developing a World-Class Antibody Portfolio with the Hope to Bring the Right Cancer Therapy for the Right Patient
Kate Sasser, Hisham Hamadeh
Read More
Market Access
Interview with the Innovators
Genmab Is Ready to Enter the US Market to Help Improve the Lives of People with Cancer
Ron Graybill, Brad Bailey
Read More
Market Access
Interview with the Innovators
Introducing Genmab-Rooted in Science and Inspired by Patients to Transform the Future of Cancer Treatment
Anthony Mancini, Ron Graybill
Read More
Interview with the Innovators
Unclear Diagnoses in Patients with Metastatic Disease
Ralph V. Boccia, MD, FACP
Read More
Interview with the Innovators
The bioT3 platform
Ralph V. Boccia, MD, FACP
Read More
Interview with the Innovators
Clinical Validation of CancerTYPE ID
Ralph V. Boccia, MD, FACP
Read More
Interview with the Innovators
CancerTYPE ID in the Clinic
Ralph V. Boccia, MD, FACP
Read More
Interview with the Innovators
CancerTREATMENT NGS+ in the Clinic
Ralph V. Boccia, MD, FACP
Read More
Page 1 of 2
Results 1 - 10 of 16